+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Global Smart Inhaler Market 2019-2025

  • PDF Icon

    Report

  • January 2020
  • Region: Global
  • Orion Market Research Private Limited
  • ID: 4901053
UP TO OFF until Dec 31st 2022
Global Smart Inhaler Market Size, Share & Trends Analysis Report by Product Type (Metered Dose Inhaler and Dry Powered Inhaler), by Application (Asthma and COPD), by End-User (Hospitals and Clinics, and Homecare) and Forecast 2019-2025.

The global smart inhaler market is expected to grow significantly over the forecast period. The increasing prevalence of asthma and COPD globally is expected to drive the market growth in the near future. Moreover, the adoption of smart inhalers is being supported by the amalgamation of sensors technology with the healthcare industry. Smart healthcare devices are enhancing the functionality of the healthcare industry. These smart inhalers generate various opportunities for people, healthcare professionals, and the government to use data from devices and develop better solutions and improve respiratory devices to support healthcare services.

The global smart inhalers market is analyzed, on the basis of regions, into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America has a well-developed healthcare infrastructure, owing to which, the companies invest largely in the development of innovative solutions for the smart inhaler market. A sedentary lifestyle and unhealthy dietary habits such as a large number of smokers are prime factors for the growing prevalence of COPD and asthma across the region. North America is an early adopter of advanced technology such as smart inhalers, and hence contribute significantly to the market growth.

In addition, the market influenced by the presence of several players operating in the global smart inhaler market. Some of the key players include GlaxoSmithKline PLC, Teva Pharmaceutical Industries Ltd., OPKO Health, Inc., ResMed, Inc., and Sensirion AG. The players operating in the market adopt various strategies such as technology development, product launch, merger and acquisitions for gaining a sustainable position in the market that further propels the growth of the market. Further, the players are bringing new product into the market by receiving approval for the same by regulatory authorities. For instance, in 2019, Teva Pharmaceutical Industries announced the approval of its AirDuo Digihaler - a sensor-enabled inhaler - from the US Food and Drug Administration (FDA). This enabled the company to expand its product offering in the global smart inhaler market.

Research Methodology

The market study of the global smart inhaler market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of the reports.

Secondary sources include:
  • Financial reports of companies involved in the market
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report is intended for smart inhalers manufacturers, suppliers and distributors, pharmaceutical industries and start-ups, contract research organizations (CROs), and government organization, for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and growth opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation:

1. Global Smart Inhaler Market Research and Analysis by Product Type
2. Global Smart Inhaler Market Research and Analysis by Application
3. Global Smart Inhaler Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive research methodology of the global smart inhaler market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global smart inhaler market.
  • Insights about market determinants which are stimulating the global smart inhaler market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. GlaxoSmithKline PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Teva Pharmaceutical Industries Ltd.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. OPKO Health, Inc.
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. ResMed, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Sensirion AG
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Smart Inhaler Market by Product Type
5.1.1. Metered Dose Inhalers
5.1.2. Dry Powder Inhalers
5.2. Global Smart Inhaler Market by Application
5.2.1. Asthma
5.2.2. COPD
5.3. Global Smart Inhaler Market by End-User
5.3.1. Hospitals and Clinics
5.3.2. Homecare
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. Japan
6.3.3. India
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. 3M Co.
7.2. Adherium Ltd.
7.3. Aptar Pharma (AptarGroup, Inc.)
7.4. AstraZeneca PLC
7.5. Boehringer Ingelheim International GmbH
7.6. Cohero Health Inc.
7.7. GlaxoSmithKline PLC
7.8. H&T Presspart Manufacturing Ltd.
7.9. Novartis International AG
7.10. OPKO Health, Inc.
7.11. ResMed, Inc.
7.12. Sensirion AG
7.13. Teva Pharmaceutical Industries Ltd.
7.14. Vectura Group PLC

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3M Co.
  • Adherium Ltd.
  • Aptar Pharma (AptarGroup, Inc.)
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cohero Health Inc.
  • GlaxoSmithKline PLC
  • H&T Presspart Manufacturing Ltd.
  • Novartis International AG
  • OPKO Health, Inc.
  • ResMed, Inc.
  • Sensirion AG
  • Teva Pharmaceutical Industries Ltd.
  • Vectura Group PLC